Rhode Island’s state-backed venture arm, the Slater Technology Fund, is investing $500,000 in Providence-based CytoSolv Inc., which is developing a treatment for diabetic ulcers and other wounds.
The company’s technology is based on wound-healing factors derived from choroid plexus, part of the blood/brain barrier that secretes proteins involved in healing into the cerebrospinal fluid.